Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IPHA · against 596 other Healthcare companies listed in US-listed
Ranked #380 of 597 · scores higher than 36% of peers · safety percentile 28
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 20–29, including IPHA · Click a bar to see the companies
Mainly because of its current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | IPHA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | Not reported | 0.23× | — | — | 33% |
| BetaLower is better · 556 reported | 0.88 | 0.95 | 54% | 33% | |
| Current ratioHigher is better · 600 reported | 0.60× | 3.91× | 1% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 376 | 1.5B USD | 29 | 43 | |
| 377 | 10.8B USD | 28 | 54 | |
| 378 | 2.5B USD | 28 | 60 | |
| 379 | 27.3B USD | 28 | 55 | |
| 380 | 149M USD | 28 | 10 | |
| 381 | 17M USD | 28 | 18 | |
| 382 | 18.2B USD | 28 | 40 | |
| 383 | 14.9B USD | 28 | 65 | |
| 384 | 393M USD | 27 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score